Accused of fueling opioid crisis, Purdue Pharma and Sacklers agree to $270 million settlement
A landmark legal settlement involving a drug company blamed for helping fuel the opioid crisis is triggering a major backlash. Purdue Pharma, the maker of oxycontin, agreed to pay $270 million to Oklahoma. The settlement allows Purdue and its controlling owners, the Sackler family, to avoid a damaging trial and to deny wrongdoing. Tony Dokoupil reports.